Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line
Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line
Recruiting · NCT04670029 · Registry updated 2021-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2021-10-08 | NCT04670029 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Weprom | 3 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CH Perpignan | Perpignan | France | 3 |
| CHRU Nancy | Nancy | France | 3 |
| CHU Jean Minjoz | Besançon | France | 9 |
| Clinique Victor Hugo / Centre Jean Bernard | Le Mans | France | 1 |
| Hôpital privé du Confluent | Nantes | France | 13 |